13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2016. See the latest, Q2 2026 →
Reported value
$290.06B
First quarter on file
Positions
430
First quarter on file
Top 10
23.5%
of the value
Est. gain
—
Nothing to compare
Est. return
—
Nothing to compare
Positions as of Mar 31, 2016, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
The 24 largest positions, 40% of the reported value, each sized by its share. Striped tiles are options.
Holdings
As of Mar 31, 2016. This is the first quarter on file, so nothing is compared yet.
| Holding | Value | |||||
|---|---|---|---|---|---|---|
| Amgen IncCOMMON STOCK | 4.6% | $13.39B | ||||
| Verizon Communications IncCOMMON STOCK | 3.1% | $9.08B | ||||
| Philip Morris InternationalCOMMON STOCK | 2.8% | $8.19B | ||||
| OracleCOMMON STOCK | 2.3% | $6.71B | ||||
| AmazonCOMMON STOCK | 2.2% | $6.51B | ||||
| Altria Group IncCOMMON STOCK | 1.7% | $5.07B | ||||
| NetflixCOMMON STOCK | 1.7% | $5.03B | ||||
| Broadcom LtdCOMMON STOCK | 1.7% | $4.86B | ||||
| Texas InstrumentsCOMMON STOCK | 1.7% | $4.80B | ||||
| Union Pacific CorpCOMMON STOCK | 1.6% | $4.59B | ||||
| Abbvie IncCOMMON STOCK | 1.5% | $4.35B | ||||
| Alexion Pharmaceuticals IncCOMMON STOCK | 1.3% | $3.84B | ||||
| Unitedhealth Group IncCOMMON STOCK | 1.3% | $3.73B | ||||
| AT&TCOMMON STOCK | 1.3% | $3.65B | ||||
| Accenture Plc Cl ACOMMON STOCK | 1.2% | $3.54B | ||||
| Coca-Cola CoCOMMON STOCK | 1.2% | $3.53B | ||||
| Canadian Natural Resources LtdCOMMON STOCK | 1.2% | $3.45B | ||||
| Stryker CorpCOMMON STOCK | 1.2% | $3.42B | ||||
| AlphabetCOMMON STOCK | 1.1% | $3.24B | ||||
| General Dynamics CorpCOMMON STOCK | 1.1% | $3.20B | ||||
| IntelCOMMON STOCK | 1.1% | $3.18B | ||||
| American International Group IncCOMMON STOCK | 1.0% | $3.05B | ||||
| Eog Resources IncCOMMON STOCK | 1.0% | $3.03B | ||||
| General Electric CoCOMMON STOCK | 1.0% | $2.94B | ||||
| Gilead Sciences IncCOMMON STOCK | 0.99% | $2.86B | ||||
| Total · 430 positions | 100% | $290.06B |
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |